Get started
Author

Thomas Kegel

The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy.
2007 · M Janusch, M Fischer, et al. · PubMed · 66
Desmoplastic small round cell tumors: Multimodality treatment and new risk factors
2019 · Monika Scheer, Christian Vokuhl, et al. · Cancer Medicine · 59
PDF
Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy
2005 · Karin Jordan, Axel Grothey, et al. · European Journal Of Haematology · 57
Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany
2014 · Dieter Hörsch, Kurt W. Schmid, et al. · Oncology Research and Treatment · 52
Venous Access Ports: Frequency and Management of Complications in Oncology Patients
2008 · Karin Jordan, Timo Behlendorf, et al. · Onkologie · 44
Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma
2005 · W. Voigt, T. Kegel, et al. · Journal of Cancer Research and Clinical Oncology · 41
e8a2 BCR–ABL: more frequent than other atypical BCR–ABL variants?
2005 · S Demehri, P Paschka, et al. · Leukemia · 41
Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer
2005 · W. Voigt, T. Kegel, et al. · Annals of Oncology · 37
Phase II Trial of Capecitabine/Irinotecan and Capecitabine/Oxaliplatin in Advanced Gastrointestinal Cancers
2004 · Karin Jordan, Olaf Kellner, et al. · Clinical Colorectal Cancer · 37
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (highdose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination
2010 · K Jordan, F Jahn, et al. · Bone Marrow Transplantation · 34
A New Chemoembolization Protocol in Refractory Liver Metastasis of Colorectal Cancer – a Feasibility Study
2002 · W. Voigt, C. Behrmann, et al. · Oncology Research and Treatment · 29
Trabectedin: Supportive care strategies and safety profile
2015 · Karin Jordan, Franziska Jahn, et al. · Critical Reviews in Oncology/Hematology · 21
Chemotherapy with Paclitaxel and Gemcitabine in Progressive Medullary and Thyroid Carcinoma of the Follicular Epithelium
2009 · A. Matuszczyk, S. Petersenn, et al. · Hormone and Metabolic Research · 21
Treatment of Adolescents and Young Adults (AYA) with Cancer in a Multidisciplinary Setting: On the Way to a Highly Specialized AYA Unit
2013 · T. Bernig, F. Jahn, et al. · Klinische Pädiatrie · 14
Phase 2 Trial of Docetaxel, Gemcitabine, and Oxaliplatin Combination Chemotherapy in Platinum- and Paclitaxel-Pretreated Epithelial Ovarian Cancer
2009 · Gregor Seliger, Lutz P. Mueller, et al. · International Journal of Gynecological Cancer · 14
Treatment of Indolent Lymphoma in Germany - Results of a Representative Population-Based Survey
2011 · Christian Schmidt, Sebastian Fetscher, et al. · Clinical Lymphoma Myeloma & Leukemia · 13
Malignization of a vestibular schwannoma 13 years after radiation therapy
2017 · S. Simmermacher, D. Vordermark, et al. · HNO · 12
Antiemetic Efficacy of an Oral Suspension of Granisetron plus Dexamethasone and Influence of Quality of Life on Risk for Nausea and Vomiting
2005 · Karin Jordan, Axel Grothey, et al. · Oncology Research and Treatment · 9
Malignisierung eines Vestibularisschwannoms 13 Jahre nach Bestrahlung
2017 · S. Simmermacher, D. Vordermark, et al. · HNO · 8
Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study
2010 · K Jordan, H H Wolf, et al. · Bone Marrow Transplantation · 7
Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006–2009
2014 · Christian Schmidt, Guenter Fingerle-Rowson, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 6
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval
2012 · Deniz Gencer, Salah-Eddin Al-Batran, et al. · Journal of Cancer Research and Clinical Oncology · 5
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
2021 · Sebastian Krug, Thomas Kegel, et al. · BMC Cancer · 4
PDF
Systemische Chemotherapie neuroendokriner Tumoren
2004 · T. Kegel, H.-J. Schmoll · Der Onkologe · 4
Recommendations for risk minimization when using Janus kinase inhibitors for the treatment of chronic inflammatory skin diseases
2023 · Johannes Wohlrab, Thomas Kegel, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 3
PDF
Works count: 60
Citation count: 663
H-index: 14
I10-index: 17
Year
Topic
Type